➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Baxter
Colorcon
Boehringer Ingelheim
Medtronic

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

CORGARD Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Corgard, and when can generic versions of Corgard launch?

Corgard is a drug marketed by Us Worldmeds Llc and is included in one NDA.

The generic ingredient in CORGARD is nadolol. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the nadolol profile page.

US ANDA Litigation and Generic Entry Outlook for Corgard

A generic version of CORGARD was approved as nadolol by MYLAN on October 31st, 1993.

  Start Trial

Drug patent expirations by year for CORGARD
Drug Prices for CORGARD

See drug prices for CORGARD

Recent Clinical Trials for CORGARD

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
BioHealthonomics Inc.Phase 2

See all CORGARD clinical trials

Pharmacology for CORGARD

US Patents and Regulatory Information for CORGARD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 AB RX Yes No   Start Trial   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CORGARD

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-004 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Medtronic
Baxter
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.